EUVIMEDEUVIMED entdecken
Crossref

High-throughput quantitative assessments of the chemical complementarity of celiac disease-related IGH CDR3s and a gliadin epitope

Rahul Jain, Max Bressler, Andrea Chobrutskiy, Boris I Chobrutskiy, George Blanck iD

International Immunology · 2024

DOI: 10.1093/intimm/dxae025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunology, 2024. Verfasst von Rahul Jain und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA. Hauptthemen laut MEDLINE: Celiac Disease, Complementarity Determining Regions, Immunoglobulin Heavy Chains, Gliadin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The long-term value of efficient antigen discovery includes gaining insights into the variety of potential cancer neoantigens, effective vaccines lacking adverse effects, and adaptive immune receptor (IR) targets for blocking adaptive IR-antigen interactions in autoimmunity. While the preceding goals have been partially addressed via big data approaches to HLA (human leukocyte antigen)-epitope binding, there has been little such progress in the big data setting for adaptive IR-epitope binding. This delay in progress for the latter is likely due to, among other things, the much more complicated adaptive IR repertoire in an individual compared to individual HLA alleles. Thus, results described here represent the application of an algorithm for efficient assessment of immunoglobulin heavy chain complementarity determining region-3 (IGH CDR3)-gliadin epitope interactions, with a focus on epitopes known to be associated with an immune response in celiac disease. The hydrophobic, chemical complementarity between celiac case IGH CDR3s and known celiac epitopes was found to be greater in comparison to the hydrophobic, chemical complementarity between the same celiac case IGH CDR3s and a series of control epitopes. Thus, the approaches indicated here likely offer guidance for the development of conveniently applied algorithms for antigen verification and discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseComplementarity Determining RegionsImmunoglobulin Heavy ChainsGliadinHumansEpitopesAlgorithms

Stichwörter der Autor:innen

adaptive immune receptor recombinationceliac disease antigencomplementarity determining region-3hydrophobic chemical complementarity

Substanzen

Complementarity Determining RegionsImmunoglobulin Heavy ChainsGliadinEpitopes

Autor:innen und Institutionen

  • Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
  • Department of Pediatrics, Oregon Health and Science University Hospital, Portland, OR 97239, USA.
  • Department of Internal Medicine, Oregon Health and Science University Hospital, Portland, OR 97239, USA.
  • Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

ORCID-Profile: George Blanck

Zitieren

APA

Jain, R., Bressler, M., Chobrutskiy, A., Chobrutskiy, B. I., & Blanck, G. (2024). High-throughput quantitative assessments of the chemical complementarity of celiac disease-related IGH CDR3s and a gliadin epitope. International Immunology. https://doi.org/10.1093/intimm/dxae025

Vancouver

Jain R, Bressler M, Chobrutskiy A, Chobrutskiy BI, Blanck G. High-throughput quantitative assessments of the chemical complementarity of celiac disease-related IGH CDR3s and a gliadin epitope. International Immunology. 2024. doi:10.1093/intimm/dxae025

BibTeX
@article{Jain2024,
  author = {Jain, Rahul and Bressler, Max and Chobrutskiy, Andrea and Chobrutskiy, Boris I and Blanck, George},
  title = {High-throughput quantitative assessments of the chemical complementarity of celiac disease-related IGH CDR3s and a gliadin epitope},
  journal = {International Immunology},
  year = {2024},
  doi = {10.1093/intimm/dxae025}
}
Kostenlos starten →